This Month in Psychopharmacology

NEI Spring Congress Highlights: Navigating Dissociative Disorders

Dr. Thomas Schwartz explored the complexities of dissociative disor...

Read More

NEI Spring Congress Highlights: GLP-1s and Brain Health – Beyond Weight Loss

At the 2025 NEI Spring Congress, Drs. McIntyre and Cutler discussed...

Read More

Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults

Prescribing stimulants, particularly amphetamines and methylphenida...

Read More

Want to Help Your Patients with Food Allergy Anxiety?

Patients with food allergies often develop anxiety surrounding the ...

Read More

Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression

A recent study provides compelling evidence supporting the use of a...

Read More

Predicting Suicidal Behaviors in Preadolescents

Suicidal thoughts and behaviors are rising among youth, especially ...

Read More

Glutamatergic Medications Show Promise for Obsessive-Compulsive and Related Disorders

A new systematic review and meta-analysis provides evidence that gl...

Read More

Antidepressant Use Before, During, and After Pregnancy

Depression is highly prevalent during pregnancy and the postpartum ...

Read More

New Research Links Depression to Increased Risk of Multiple Chronic Diseases

Mood disorders are increasingly viewed as whole-body conditions aff...

Read More

Rheumatoid Arthritis Linked to Faster Cognitive Decline in Dementia Patient

Rheumatoid arthritis (RA) has been linked to an increased risk of d...

Read More

Study Demonstrates Success in Shifting Adolescent Sleep Patterns Through Targeted Interventions

A recent study examined whether a motivational group-based sleep in...

Read More

FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment

The FDA recently approved. AXS-07 is an oral, rapidly absorbed, mul...

Read More